These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35935194)

  • 1. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
    Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
    Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Tang Y; Luo QX; Wang N; Tang L; Yang XJ; You XF; Wang YC; Liang L; Zhang JB; Su B; Sha W
    Eur J Med Res; 2024 Mar; 29(1):147. PubMed ID: 38429734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood
    Vickers MA; Darboe F; Muefong CN; Mbayo G; Barry A; Gindeh A; Njie S; Riley AJ; Sarr B; Sambou B; Dockrell HM; Charalambous S; Rachow A; Owolabi O; Jayasooriya S; Sutherland JS
    Front Immunol; 2020; 11():572620. PubMed ID: 33679684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Wang N; Tang L; Yang XJ; Tang Y; Li L; Wu WF; Su B; Sha W
    BMC Infect Dis; 2022 Dec; 22(1):899. PubMed ID: 36457066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Phenotype and Functionality of
    Mupfumi L; Mpande CAM; Reid T; Moyo S; Shin SS; Zetola N; Mogashoa T; Musonda RM; Kasvosve I; Scriba TJ; Nemes E; Gaseitsiwe S
    Pathogens; 2020 Mar; 9(3):. PubMed ID: 32131556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired
    Ssekamatte P; Nabatanzi R; Sitenda D; Nakibuule M; Bagaya BS; Kibirige D; Kyazze AP; Kateete DP; Sande OJ; van Crevel R; Cose S; Biraro IA
    Front Immunol; 2024; 15():1480739. PubMed ID: 39430752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates
    Li Y; Yang Z; Ge Q; Zhang Y; Gao M; Liu X; Zhang L
    Infect Drug Resist; 2024; 17():3385-3393. PubMed ID: 39131518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
    Day CL; Moshi ND; Abrahams DA; van Rooyen M; O'rie T; de Kock M; Hanekom WA
    PLoS One; 2014; 9(4):e94949. PubMed ID: 24740417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-Stratified T Cell Responses in Children Infected with
    Dreesman A; Corbière V; Dirix V; Smits K; Debulpaep S; De Schutter I; Libin M; Singh M; Malfroot A; Locht C; Mascart F
    Front Immunol; 2017; 8():1059. PubMed ID: 28928738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.